Last reviewed · How we verify
Dapagliflozin and Sitagliptin
Dapagliflozin and Sitagliptin is a Small molecule drug developed by SK Chemicals Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | Dapagliflozin and Sitagliptin |
|---|---|
| Sponsor | SK Chemicals Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dapagliflozin and Sitagliptin CI brief — competitive landscape report
- Dapagliflozin and Sitagliptin updates RSS · CI watch RSS
- SK Chemicals Co., Ltd. portfolio CI
Frequently asked questions about Dapagliflozin and Sitagliptin
What is Dapagliflozin and Sitagliptin?
Dapagliflozin and Sitagliptin is a Small molecule drug developed by SK Chemicals Co., Ltd..
Who makes Dapagliflozin and Sitagliptin?
Dapagliflozin and Sitagliptin is developed by SK Chemicals Co., Ltd. (see full SK Chemicals Co., Ltd. pipeline at /company/sk-chemicals-co-ltd).
What development phase is Dapagliflozin and Sitagliptin in?
Dapagliflozin and Sitagliptin is in Phase 1.